Log In
Print
BCIQ
Print
Print this Print this
 

VBP15

  Manage Alerts
Collapse Summary General Information
Company ReveraGen BioPharma Inc.
DescriptionDissociative glucocorticoid and inhibitor of NF-kappa B (NF-kB)
Molecular Target Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)
Mechanism of ActionNF-kappa B (NF-kB) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today